Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Russell E. Ware, MD, PhD
Researcher Director of Division of Hematology
Cincinnati Children’s Hospital Medical Center
3333 Burnet Avenue
Cincinnati, Ohio, United States
Russell Ware, MD, PhD, has been involved with a wide variety of clinical and translational hematology research projects for over 25 years, but his primary interests have focused on sickle cell disease. Dr. Ware has substantial personal experience with directing patient-oriented research, and he currently runs an NIH-funded laboratory effort that investigates genetic modifiers of sickle cell disease.
The main focus of his lab research is to understand the phenotypic variability that occurs with hydroxyurea treatment, through the study of hydroxyurea pharmacokinetics, pharmacodynamics, pharmacogenetics, and pharmacogenomics. Dr. Ware is also the national principal investigator for several NIH-funded multicenter sickle cell clinical trials, including the recently completed Stroke With Transfusions Changing to Hydroxyurea (SWiTCH), and the current TCD With Transfusions Changing to Hydroxyurea (TWiTCH) and Sparing Conversion to Abnormal TCD Elevations (SCATE) studies that include non-US clinical sites.
Most recently, Dr. Ware has moved his research efforts into the international arena, starting SCD pilot screening programs in Angola, and now conducting clinical trials to determine the safety and efficacy of hydroxyurea in developing countries.
+myBinderRelated Content
-
David Beidler, PhDAs the Translational Sciences lead for t...
-
Robert Molokie, MDDr. Robert Molokie is a hematologist and...
-
Webinar Series: Sickle Cell Science: Path to Progress – Bone Marrow Transplants, Other Therapies, and Sickle C...To commemorate Sickle Cell Awareness Mon...
-
Augusta University Sickle Cell CenterLocated in Augusta, Georgia, Augusta Uni...
-
Christiana Care Sickle Cell ProgramChristiana Care is one of the country’...
-
Comparison of Adult and Adolescent Quality of Ambulatory and Emergency Care in Sickle Cell Disease: Ascq-Me and the ...Quality of care (QOC) has been anecdotal...
-
Use of telemedicine to improve access to clinical services and treatment for children with sickle cell diseasePatients with sickle cell disease (SCD) ...
